These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16112122)

  • 1. Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice.
    Mazzolai L; Korber M; Bouzourene K; Aubert JF; Nussberger J; Stamenkovic I; Hayoz D
    Atherosclerosis; 2006 May; 186(1):86-91. PubMed ID: 16112122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.
    Tomiyama-Hanayama M; Rakugi H; Kohara M; Mima T; Adachi Y; Ohishi M; Katsuya T; Hoshida Y; Aozasa K; Ogihara T; Nishimoto N
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F679-84. PubMed ID: 19570877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice.
    Mazzolai L; Duchosal MA; Korber M; Bouzourene K; Aubert JF; Hao H; Vallet V; Brunner HR; Nussberger J; Gabbiani G; Hayoz D
    Hypertension; 2004 Sep; 44(3):277-82. PubMed ID: 15302839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
    Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
    Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice.
    Nogueira BV; Peotta VA; Meyrelles SS; Vasquez EC
    Arch Med Res; 2007 Nov; 38(8):816-21. PubMed ID: 17923260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.
    Fujino T; Nakagawa N; Yuhki K; Hara A; Yamada T; Takayama K; Kuriyama S; Hosoki Y; Takahata O; Taniguchi T; Fukuzawa J; Hasebe N; Kikuchi K; Narumiya S; Ushikubi F
    J Clin Invest; 2004 Sep; 114(6):805-12. PubMed ID: 15372104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
    Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
    Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice.
    Ong JM; Zorapapel NC; Rich KA; Wagstaff RE; Lambert RW; Rosenberg SE; Moghaddas F; Pirouzmanesh A; Aoki AM; Kenney MC
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1891-900. PubMed ID: 11431458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides buffer renin-dependent hypertension.
    Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells.
    Zechariah A; ElAli A; Hagemann N; Jin F; Doeppner TR; Helfrich I; Mies G; Hermann DM
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1561-7. PubMed ID: 23559636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
    Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells.
    Ni J; Ma KL; Wang CX; Liu J; Zhang Y; Lv LL; Ni HF; Chen YX; Ruan XZ; Liu BC
    Lipids Health Dis; 2013 Apr; 12():49. PubMed ID: 23570453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.